secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zomedica Corp. (ZOMDF)
CIK:        0001684144
Form:       8-K
Filed at:   2021-11-26T23:59:59+00:00
Accession:  0001654954-21-012630
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zomedica CCO Bruk Herbst departs; separation agreement with benefits for termination without cause
--------------------------------------------------------------------------------

- Bruk Herbst separated from Zomedica as Chief Commercial Officer effective Nov 19, 2021.
- Separation agreement provides benefits for termination without cause per his employment agreement and home office equipment (excluding laptop).
- Agreement includes mutual release of claims, confidentiality, non-disparagement, and non-solicitation obligations.
- Herbst had 21 days to consider and 7 days to revoke the agreement; it was signed on Nov 19, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1684144/000165495421012630/0001654954-21-012630-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1684144/000165495421012630/zom_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-012630

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer